CClinicalTrials.gg

Lung Diseases, Obstructive clinical trials

The registry lists 2,597 studies for Lung Diseases, Obstructive across more than 10 countries. 203 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-09.

Status

Completed
1,728
Status unknown
389
Terminated
157
Recruiting
126
Withdrawn
78
Not yet recruiting
67

Phase

Phase 3
312
Phase 2
305
Phase 4
245
Phase 1
142
Early Phase 1
22

Where

United States
591
United Kingdom
290
Germany
259
Canada
212
China
191
France
177

Who runs them

AstraZeneca (153) · GlaxoSmithKline (93) · Boehringer Ingelheim (75) · Novartis Pharmaceuticals (74) · Chiesi Farmaceutici S.p.A. (35) · Imperial College London (28) · National Heart, Lung, and Blood Institute (NHLBI) (28) · Riphah International University (27)

Studies

Recruiting first, then most recently updated. Showing 50 of 2,597 — search for more.